Cohen-Barak O, Radivojevic A, Jones A, Fiedler-Kelly J, et al. Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach. Cephalalgia 2021 May 17:3331024211007789. doi: 10.1177/03331024211007789.
PMID: 34000848